QA: KIORA PHARMACEUTICALS INC in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001372514_2023_KIORA_PHARMACEUTICALS_INC.pdf

Logs

Graph

Absolute values for 0001372514, KIORA PHARMACEUTICALS INC

  xvar xval
0 AssetsCurrent 7,680,666
1 IntangibleAssetsNetIncludingGoodwill 10,743,164
2 PropertyPlantAndEquipmentNet 55,177
3 remainder_Assets 199,252
4 LiabilitiesCurrent 3,272,363
5 LiabilitiesNoncurrent 3,998,296
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 8,277,993
9 ResearchAndDevelopmentExpense 3,448,925
10 remainder_Expenses 469,595
11 remainder_Revenues 0
12 remainder_NetIncome -1,387,097
13 remainder_ComprehensiveNetIncome -96,310
  yvar yval
0 Assets 18,678,259
1 Liabilities 7,270,659
2 Expenses 12,196,513
3 Revenues 0
4 StockholdersEquity 11,407,600
5 NetIncome -13,583,610
6 ComprehensiveNetIncome -13,631,765
7 BaseVar 19,814,419
8 EconomicCapitalRatio 0.462

Edgar->Model Mapping

Feature Distribution

Change over Time